KATHRYN FELTS: Open Payments
NPI 1750019774 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 39 payments from 7 companies in 2025. Trend: 2023 $729 · 2024 $636 · 2025 $833
Food & beverage: $734Education: $99
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $275 |
| Janssen Biotech, Inc. | 10 | $264 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $130 |
| Ardelyx, Inc. | 4 | $62 |
| ABBVIE INC. | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| Novo Nordisk Inc | 1 | $20 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, IBSRELA, LINZESS, EOHILIA, VOQUEZNA, Wegovy.
Industry payments across VA — which companies pay providers there.
